The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation :Insights from the danish diet, cancer, and health study

Chest

Volumn 145, Issue 3, 2014, Pages 559-566

  Albertsen, Ida Ehlers ^a,d   Rasmussen, Lars Hvilsted ^b   Lane, Deirdre A ^d   Overvad, Thure Filskov ^a,d   Skjøth, Flemming ^a   Overvad, Kim ^c   Lip, Gregory Y H ^b,d   Larsen, Torben Bjerregaard ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K;

ADULT; AGED; ARTERIAL THROMBOEMBOLISM; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING;

ATRIAL FIBRILLATION; CAUSE OF DEATH; DENMARK; DIET; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SMOKING; THROMBOEMBOLISM; TIME FACTORS;

EID: 84896803420     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1740     Document Type: Article

References (31)

1. The Gallup Organisation, Hungary.Flash Eurobarometer No 253. Survey on Tobacco. Analytical report. 2009.European Commission website. http://ec.europa.eu/public-opinion/flash/fl-253e-n.pdf.Accessed July 26, 2013
2. Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA.Smoking and smoking cessation in relation to mortality in women.JAMA.2008; 299 (17):2037-2047
3. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women.JAMA.1993; 269 (2):232-236
4. Shinton R, Beevers G.Meta-analysis of relation between cigarette smoking and stroke.BMJ.1989; 298 (6676):789-794
5. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ.Cigarette smoking as a risk factor for stroke. The Framingham Study.JAMA.1988; 259 (7):1025-1029
6. Chamberlain AM, Agarwal SK, Folsom AR, et al. Smoking and incidence of atrial fi brillation: results from the Atherosclerosis Risk in Communities (ARIC) study.Heart Rhythm.2011; 8 (8): 1160-1166
7. Heeringa J, Kors JA, Hofman A, van Rooij FJA, Witteman JCM. Cigarette smoking and risk of atrial fi brillation: the Rotterdam Study.Am Heart J.2008; 156 (6):1163-1169
8. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE. The natural history of atrial fi brillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.Am J Med.1995; 98 (5):476-484
9. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA.Independent risk factors for atrial fi brillation in a population-based cohort. The Framingham Heart Study.JAMA.1994; 271 (11):840-844
10. Lloyd-Jones DM, Wang TJ, Leip EP, et al.Lifetime risk for development of atrial fi brillation: the Framingham Heart Study.Circulation.2004; 110 (9):1042-1046
11. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fi brillation on the risk of death: the Framingham Heart Study.Circulation.1998; 98 (10):946-952
12. You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fi brillation: antithrombotic therapy and preven tion of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest.2012;141 (2-suppl):e531S-e575S
13. Camm AJ, Kirchhof P, Lip GY, et al European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery.Guidelines for the management of atrial fi brillation: the Task Force for the Management of Atrial Fibrillation ofthe European Society of Cardiology (ESC).Eur Heart J.2010;31 (19):2369-2429
14. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM.Refi ning clinical risk stratification for predicting stroke and thromboembolism in atrial fi brillation using a novel risk factorbased approach: the Euro Heart Survey on atrial fi brillation. Chest.2010; 137 (2):263-272
15. Lip GYH, Frison L, Halperin JL, Lane DA.Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemesin an anticoagulated atrial fi brillation cohort.Stroke.2010; 41 (12):2731-2738
16. Atrial Fibrillation Investigators.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fi brillation. Analysis of pooled data from fi ve randomized controlled trials.Arch Intern Med.1994; 154 (13):1449-1457
17. Ezekowitz MD, Bridgers SL, James KE, et al; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.Warfarin in the prevention of stroke associated withnonrheumatic atrial fi brillation.N Engl J Med.1992; 327 (20):1406-1412
18. Stroke Prevention in Atrial Fibrillation Investigators.Stroke prevention in atrial fi brillation study. Final results.Circulation.1991; 84 (2):527-539
19. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fi brillation. N Engl J Med.1990; 323 (22):1505-1511
20. Tjønneland A, Olsen A, Boll K, et al.Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark.Scand J Public Health.2007; 35 (4):432-441
21. Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving.Scand J Public Health.2011; 39 (suppl 7):12-16
22. Hart RG, Pearce LA, Aguilar MI.Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.Ann Intern Med.2007; 146 (12):857-867
23. Hosmer DW, Lemeshow S, May S. Applied Survival Analysis: Regression Modeling of Time-to-Event Data.Hoboken, NJ:John Wiley & Sons, Inc; 1999
24. Harrell FE. Regression Modeling Strategies.1st ed. New York, NY: Springer-Verlag; 2001
25. Heagerty PJ, Lumley T, Pepe MS.Time-dependent ROC curves for censored survival data and a diagnostic marker.Biometrics.2000; 56 (2):337-344
26. Chambless LE, Cummiskey CP, Cui G.Several methods to assess improvement in risk prediction models: extensio to survival analysis.Stat Med.2011; 30 (1):22-38
27. Novello P, Ajmar G, Bianchini D, et al.Ischemic stroke and atrial fi brillation. A clinical study.Ital J Neurol Sci.1993;14 (7):571-576
28. Friberg L, Benson L, Rosenqvist M, Lip GYH.Assessment of female sex as a risk factor in atrial fi brillation in Sweden: nationwide retrospective cohort study.BMJ.2012; 344: e3522
29. Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L.Sex differences in stroke risk among older patients with recently diagnosed atrial fi brillation. JAMA.2012; 307 (18):1952-1958
30. Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB; Copenhagen City Heart Study.Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study).Am J Cardiol.2004; 94 (7):889-894
31. Rix TA, Riahi S, Overvad K, Lundbye-Christensen S, Schmidt EB, Joensen AM.Validity of the diagnoses atrial fi brillation and atrial flutter in a Danish patient registry.Scand Cardiovasc J.2012; 46 (3):149-153